Trial Profile
Prospective, randomized, open-label study comparing efficacy of fixed dose brimonidine-timolol (FCBT) and fixed dose of dorzolamide -timolol (FCDT) in patients with elevated intraocular pressure (IOP) after intravitreal triamcinolone acetonide injections (IVTA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Brimonidine/timolol (Primary) ; Dorzolamide/timolol (Primary)
- Indications Ocular hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 27 Oct 2015 New trial record